Literature DB >> 4578369

Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

R N Brogden, T M Speight, G S Avery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4578369     DOI: 10.2165/00003495-197305010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  166 in total

1.  STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST.

Authors:  H F FRASER; D E ROSENBERG
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  THE RESPIRATORY AND SUBJECTIVE EFFECTS OF PENTAZOCINE.

Authors:  J W BELLVILLE; J GREEN
Journal:  Clin Pharmacol Ther       Date:  1965 Mar-Apr       Impact factor: 6.875

3.  An assessment of the analgesic efficacy of oral pentazocine.

Authors:  I Davie; A H Masson
Journal:  Br J Anaesth       Date:  1970-02       Impact factor: 9.166

4.  Effects of short- and long-term administration of pentazocine in man.

Authors:  D R Jasinski; W R Martin; R D Hoeldtke
Journal:  Clin Pharmacol Ther       Date:  1970 May-Jun       Impact factor: 6.875

5.  [Trials with Pentazocine in postoperative pain. A preliminary report].

Authors:  M Swerdlow; A Dalal
Journal:  Anaesthesist       Date:  1966-02       Impact factor: 1.041

6.  Pharmacokinetic studies on pentazocine.

Authors:  M Mitchard
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

7.  A comparison of the effects of pentazocine and pethidine administered during labour.

Authors:  J Moore; R M Carson; R J Hunter
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-09

8.  A comparison of the analgesic effects of pentazocine and morphine in patients with cancer.

Authors:  W T Beaver; S L Wallenstein; R W Houde; A Rogers
Journal:  Clin Pharmacol Ther       Date:  1966 Nov-Dec       Impact factor: 6.875

9.  The absorption and excretion of pentazocine after administration by different routes.

Authors:  R A Burt; A H Beckett
Journal:  Br J Anaesth       Date:  1971-05       Impact factor: 9.166

10.  Differential distribution of pentazocine-3H and cis-3-chloroallylnorpentazocine-3H in the cat.

Authors:  R A Ferrari
Journal:  Toxicol Appl Pharmacol       Date:  1968-05       Impact factor: 4.219

View more
  10 in total

1.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 2.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

4.  [Detection of pentazocin (Fortral) in human urine: gas chromatographic/mass spectrometric studies].

Authors:  W Gielsdorf; E Klug; M Tümmers
Journal:  Z Rechtsmed       Date:  1982

Review 5.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

6.  Induction of physical dependence in rats by short interval medication.

Authors:  Y Koga
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

Review 7.  Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

8.  Pentazocine-induced agranulocytosis.

Authors:  H Haibach; Y W Yesus; J J Doggett
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

9.  Rational use of analgesics in the treatment of the rheumatic disorders.

Authors:  F D Hart
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

10.  Double-blind comparison of the analgesic response to oral ciramadol (WY-15.705) and pentazocine in post-operative pain.

Authors:  F Camu
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.